Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1752 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Unknown  Blood Test for Breast Cancer Associated Auto Antibodies
Condition: Breast Cancer
Intervention:
22 Recruiting Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:
Condition: Breast Cancer
Intervention:
23 Recruiting Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer;   Gastric Cancer
Intervention: Biological: MGAH22
24 Recruiting Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
Condition: Breast Cancer
Intervention: Behavioral: LIVESTRONG
25 Unknown  Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: carboplatin;   Drug: gemcitabine hydrochloride
26 Recruiting A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Other: treated recommended
27 Recruiting Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Erlotinib Hydrochloride;   Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Capecitabine;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
28 Recruiting A Phase I, Multicenter, Open-Label, Two-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer
Condition: Advanced ER+, HER2-Negative Breast Cancer
Intervention: Drug: RAD1901
29 Unknown  Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
Condition: Breast Cancer
Intervention: Device: SoftScan Optical Breast Imaging System
30 Recruiting Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer
Condition: Her2normal
Intervention: Drug: eribulin mesylate
31 Recruiting The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Intervention: Other: Questionnaires, Oncotype Dx Assay
32 Recruiting Preoperative and Intraoperative Quantification of Axillary Tumoral Load
Condition: Breast Cancer
Intervention:
33 Recruiting Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Conditions: Ovarian Cancer;   Breast Cancer
Interventions: Drug: BKM120 and Olaparib;   Drug: BYL719 and Olaparib
34 Not yet recruiting Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor
Conditions: Invasive Breast Cancer;   Estrogen Receptor Positive
Intervention:
35 Recruiting Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer
Conditions: Breast Cancer;   Hypoxia
Interventions: Other: 18FMISO PET/CT scan;   Drug: Letrozole
36 Recruiting Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Malignant Tumor of the Breast
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine
37 Recruiting A Study Evaluating Perjeta (Pertuzumab) Combined With Herceptin (Trastuzumab) and Standard Anthracycline-based Chemotherapy in Patients With HER2-positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer.
Condition: Breast Cancer
Interventions: Drug: 5-fluorouracil;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin;   Drug: epirubicin;   Drug: paclitaxel;   Drug: pertuzumab [Perjeta];   Drug: trastuzumab [Herceptin]
38 Unknown  18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound
Condition: Breast Neoplasms
Intervention: Drug: 18F-FLT
39 Recruiting Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Conditions: Breast Cancer;   Cervical Cancer;   Colon Cancer;   Leukemia;   Lymphoma;   Malignant Neoplasm;   Melanoma;   Rectal Cancer
Interventions: Other: educational intervention;   Behavioral: telephone-based intervention;   Other: questionnaire administration
40 Recruiting Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: Reparixin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years